SMC Mozambique Bill and Melinda Gates Foundation Phase 2
The study aims to test the feasibility, effectiveness and chemoprevention efficacy of SMC with SPAQ in an area of Mozambique where malaria transmission is highly seasonal.This implementation research study uses a convergent mixed-methods approach. SMC will be implemented in four monthly cycles between November 2021 and February 2022. The research will involve documenting the process of further adapting the intervention to the context in Mozambique, as well as conducting a representative end-of-round household survey to determine coverage and quality of SMC implementation.
Start date
15/09/2021
End date
30/06/2023
Country/
Countries
Countries
Africa >
Mozambique
Funder
Bill & Melinda Gates Foundation
Funding
1862922.00(USD)
